Advanced Filters
noise

Minatoga, Japan Clinical Trials

A listing of Minatoga, Japan clinical trials actively recruiting patients volunteers.

Found 65,447 clinical trials

A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

This study will evaluate the safety and effectiveness of mirogabalin in adult patients with diabetic peripheral neuropathic pain (DPNP) in real-world clinical practice setting in China.

18 years of age All Phase N/A
M Miguel Angel Fernandez-Vaquero, MD,PhD

Video Classification of Intubation in Spain (VCI)

Use of VCI in Spain

- 18 years of age All Phase N/A
M Ming Lv, MD,PhD

Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China

The incidence of vertebrobasilar dissecting aneurysms (VBDAs) is about 1/100,000~1.5/100,000, and it is one of the most important causes of stroke in young and middle-aged people. In recent years, with the development of medical imaging technology, the detection rate of this disease has been increasing year by year. The natural …

18 - 80 years of age All Phase N/A
C Charles Mack, MD

STICH3C Cardiac Magnetic Resonance Observational Study

STICOS will test the hypothesis that residual jeopardized myocardium, late gadolinium enhancement, and non-ischemic substrate after revascularization is associated with postoperative adverse cardiovascular events such as heart failure , readmission, or death. This study will look at whether certain heart tissue abnormalities seen on MRI scans can help predict serious …

18 years of age All Phase N/A
J Jean-Philippe Empana

Risk Markers of Arterial Aging. The Paris Prospective Study III-2

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

60 - 95 years of age All Phase N/A
A Alejandro Ledesma, M.Sc

Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD

CASCADE (Colorectal Analysis for Signature Cancer Assessment Using delta-HLD Technology) is a proof-of-concept case-control study designed to evaluate the performance of delta-HLD, Epiliquid's proprietary liquid biopsy technology, for the detection of colorectal cancer. Epiliquid also integrates a proprietary bioinformatic system capable of identifying, ranking, and selecting tumor-specific methylation biomarkers for …

45 - 75 years of age All Phase N/A
Q Qiang Dong, Professor

Shanghai Prospective Registry Study of Ischemic Stroke

This study aims to conduct a prospective cohort study on patients with imaging-confirmed ischemic stroke based on the 4S database. The primary objectives are to investigate the incidence, clinical characteristics, risk factors, and pathophysiological mechanisms of young-onset stroke, as well as to analyze the evolving trends in the etiology of …

18 years of age All Phase N/A
M MASCAUX Céline, MD

Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients

Lung cancer is the leading cancer in France in terms of mortality. The prognosis of the disease is closely correlated with the diagnostic stage and the majority of patients are diagnosed at a metastatic stage. The arrival of immunotherapy has made it possible to change the therapeutic paradigm by significantly …

18 years of age All Phase N/A
N Niklas Breindahl, MD

The DAnish VIdeo IntubaTION (DA-VITION) Study

This study aims to train an AI for video-directed endotracheal intubation (VITION) to recognise the anatomical structures of the upper airway during video-directed endotracheal intubations.

years of age All Phase N/A
S Sébastien MIRANDA

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Venous thromboembolic disease is a common pathology in the general population (1.5/1000), the prognosis of which depends in particular on the risk of recurrence. This risk depends essentially on whether the thrombotic episode was provoked or not. Thus, patients who present a thromboembolic event without any contributing factor have a …

18 years of age All Phase N/A

Simplify language using AI